Transpacific Venture Partners

TransPacific Venture Partners (TPV) is an Asia-based venture capital firm focused on early-stage medical technology ventures. TPV identifies unmet healthcare needs, funding and supporting companies developing impactful new medical products. The firm applies its extensive industry expertise and relationships, assisting portfolio companies in navigating development and achieving key milestones.

Founded by Dr. Michelle Lin, General Partner, the firm leverages her background in policy development and leadership within Taiwan's medtech industry. Dr. Peter J. Fitzgerald, an Interventional Cardiologist and Stanford Professor, contributes extensive clinical, technological, and entrepreneurial experience from numerous medical device startups, informing TPV's investment approach.

TransPacific Venture Partners supports early-stage medical technology companies, providing strategic capital and guidance. Positioned to discover medtech innovations across Asia, the firm offers local entrepreneurs a global perspective. Its vision is to cultivate these ventures, bringing healthcare innovations to patients worldwide and to expanding Asian markets.